Prostate cancer in transgender women: considerations for screening, diagnosis and management

F Crowley, M Mihalopoulos, S Gaglani… - British Journal of …, 2023 - nature.com
Abstract Transgender individuals represent 0.55% of the US population, equivalent to 1.4
million transgender adults. In transgender women, feminisation can include a number of …

[HTML][HTML] Recent advances in optical and photoelectrochemical nanobiosensor technology for cancer biomarker detection

M Ahmad, M Hasan, N Tarannum, S Ahmed - … and Bioelectronics: X, 2023 - Elsevier
Cancer remains the most lethal disease in today's scientific and technological age, claiming
the lives of thousands of people every day. In many cases, cancer can be cured with our …

Development and validation of an endometriosis diagnostic method based on serum biomarkers and clinical variables

B Herranz-Blanco, E Daoud, P Viganò… - Biomolecules, 2023 - mdpi.com
Endometriosis affects more than 10% of women of reproductive age, significantly impacting
their quality of life. Diagnosis typically takes 4 to 11 years from symptom onset. The gold …

Ethnic differences in prostate-specific antigen levels in men without prostate cancer: a systematic review

M Barlow, L Down, LTA Mounce, SWD Merriel… - Prostate Cancer and …, 2023 - nature.com
Introduction Black men are twice as likely to be diagnosed with prostate cancer than White
men. Raised prostate-specific antigen (PSA) levels can indicate an increased risk of prostate …

Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK …

HD Green, SWD Merriel, RA Oram, KS Ruth… - British Journal of …, 2022 - nature.com
Background Prostate cancer is highly heritable, with> 250 common variants associated in
genome-wide association studies. It commonly presents with non-specific lower urinary tract …

The Transcriptomic Profiles of ESR1 and MMP3 Stratify the Risk of Biochemical Recurrence in Primary Prostate Cancer beyond Clinical Features

M Olczak, MJ Orzechowska, AK Bednarek… - International Journal of …, 2023 - mdpi.com
The molecular determinants of the heterogenic course of prostate cancer (PC) remain
elusive. We aimed to determine the drivers predisposing to unfavorable PC outcomes …

Clinical biofluid assays for prostate cancer

T Borbiev, I Kohaar, G Petrovics - Cancers, 2023 - mdpi.com
Simple Summary Prostate cancer (PCa) is the most frequent malignancy, and the second
leading cause of cancer-related death, in men in the United States. PCa detection has been …

OncoUroMiR: Circulating miRNAs for Detection and Discrimination of the Main Urological Cancers Using a ddPCR-Based Approach

JP Sequeira, D Barros-Silva, P Ferreira-Torre… - International journal of …, 2023 - mdpi.com
The three most common genitourinary malignancies (prostate/kidney/bladder cancers)
constitute a substantial proportion of all cancer cases, mainly in the elderly population. Early …

Risk-stratified multi-round PSA screening for prostate cancer integrating the screening reference level and subgroup-specific progression indicators

X Liu, Y Zhang, H Duan, L Yang, C Sheng… - European Journal of …, 2023 - Springer
Background Although prostate-specific antigen (PSA) is widely used in prostate cancer
(PCa) screening, nearly half of PCa cases are missed and less than one-third of cases are …

Prostate age gap: An MRI surrogate marker of aging for prostate cancer detection

A Fernandez‐Quilez, T Nordström… - Journal of Magnetic …, 2023 - Wiley Online Library
Background Aging is the most important risk factor for prostate cancer (PC). Imaging
techniques can be useful to measure age‐related changes associated with the transition to …